Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ambroxol hydrochloride inhalation solution for sticky sputum symptoms in lower respiratory tract infection
CTR20170341Phase 3Active
- Sponsor
- Ruiyang Pharmaceutical
- Start
- Jun 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of ambroxol in pulmonary infection, sponsored by Ruiyang Pharmaceutical. Started Jun 2017; status: active.
02
Drugs
ambroxol
03
Conditions
pulmonary infection
Beyond the preview
Go deeper on CTR20170341.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20170341.